Details of the Drug
General Information of Drug (ID: DMZ3EML)
Drug Name |
Di(2,6-dimethylphenol)
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2417-04-1; 2,2',6,6'-tetramethyl-4,4'-biphenol; 3,3',5,5'-tetramethylbiphenyl-4,4'-diol; di(2,6-dimethylphenol); 2,2',6,6'-Tetramethyl-p,p'-biphenol; CHEMBL449983; [1,1'-Biphenyl]-4,4'-diol, 3,3',5,5'-tetramethyl-; 3,3',5,5'-tetramethyl-4,4'-diallyloxybiphenyl; 3,3,5,5-Tetramehtyl [1,1'-biphenyl] 4,4'-diol; 4-(4-hydroxy-3,5-dimethylphenyl)-2,6-dimethylphenol; 3,3',5,5'-TETRAMETHYL-4,4'-DIHYDROXYBIPHENYL; 3,3,5,5-Tetramethylbiphenyl-4,4-diol; 4,4'-dihydroxy-3,3',5,5'-tetramethyl-biphenyl
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 242.31 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||